Impact of Cardiovascular Diseases on Mortality in Gastric Cancer Patients with Preexisting Chronic Disease
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Chronic diseases and cardiovascular diseases (CVD) have been independently linked to poorer cancer outcomes. This study investigated whether gastric cancer patients with hypertension, diabetes, or dyslipidemia have higher mortality if diagnosed with CVD in the past year before cancer diagnosis. Materials and Methods: Data were obtained from the National Health Insurance database for 2002 to 2019. The study population consisted of gastric cancer patients with hypertension, diabetes, or dyslipidemia. The outcome measure was 5-year mortality in re lation to incident status of CVD within 1 year before cancer diagnosis. A survival analysis was conducted using the Cox proportion al hazards model. Subgroup analysis was conducted according to age, economic status, and type of hospital first visited for cancer treatment. Results: Of a total of 6458 individuals, 2123 (32.7%) were diagnosed with CVDs in the past year before cancer diagnosis. Compared to participants without a history of CVD, those who were diagnosed with CVD showed a higher risk of 5-year mortality (hazard ra tio 1.259, 95% confidence interval 1.138–1.394). The extent to which the mortality risk differed between those with and without CVD was greater for individuals of low economic status and in those receiving their initial cancer treatment in a general hospital. Conclusion: Patients with gastric cancer and hypertension, diabetes, or dyslipidemia diagnosed with CVD within 1 year before their cancer diagnosis had a higher mortality risk, emphasizing the importance of managing cancer patients with chronic disease and subsequent incidence of CVDs.
Abstract
Purpose: Chronic diseases and cardiovascular diseases (CVD) have been independently linked to poorer cancer outcomes. This study investigated whether gastric cancer patients with hypertension, diabetes, or dyslipidemia have higher mortality if diagnosed with CVD in the past year before cancer diagnosis. Materials and Methods: Data were obtained from the National Health Insurance database for 2002 to 2019. The study population consisted of gastric cancer patients with hypertension, diabetes, or dyslipidemia. The outcome measure was 5-year mortality in re lation to incident status of CVD within 1 year before cancer diagnosis. A survival analysis was conducted using the Cox proportion al hazards model. Subgroup analysis was conducted according to age, economic status, and type of hospital first visited for cancer treatment. Results: Of a total of 6458 individuals, 2123 (32.7%) were diagnosed with CVDs in the past year before cancer diagnosis. Compared to participants without a history of CVD, those who were diagnosed with CVD showed a higher risk of 5-year mortality (hazard ra tio 1.259, 95% confidence interval 1.138–1.394). The extent to which the mortality risk differed between those with and without CVD was greater for individuals of low economic status and in those receiving their initial cancer treatment in a general hospital. Conclusion: Patients with gastric cancer and hypertension, diabetes, or dyslipidemia diagnosed with CVD within 1 year before their cancer diagnosis had a higher mortality risk, emphasizing the importance of managing cancer patients with chronic disease and subsequent incidence of CVDs.
참고문헌 (30)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Wong MCS, "Global incidence and mortality of gastric cancer, 1980-2018", JAMA Netw Open, 4, pp.e2118457~ (2021)
- GBD 2017 Stomach Cancer Collaborators, "The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017 : a systematic analysis for the Global Burden of Disease study 2017", Lancet Gastroenterol Hepatol, 5, pp.42~54 (2020)
- 엄방울, "Trends in Gastric Cancer Incidence According to the Clinicopathological Characteristics in Korea, 1999-2014", Cancer Research and Treatment, 50(4), pp.1343~1350 (2018), 대한암학회
- 강미주, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019", Cancer Research and Treatment, 54(2), pp.330~344 (2022), 대한암학회[DOI]
- Sekiguchi M, "Epidemiological trends and future perspectives of gastric cancer in Eastern Asia", Digestion, 103, pp.22~28 (2022)
- Ha R, "A national pilot program for chronic diseases and health inequalities in South Korea", BMC Public Health, 21, pp.1142~ (2021)
- Tu H, "Cancer risk associated with chronic diseases and disease markers : prospective cohort study", BMJ, 360, pp.k134~ (2018)
- Petrie JR, "Diabetes, hypertension, and cardiovascular disease : clinical insights and vascular mechanisms", Can J Cardiol, 34, pp.575~584 (2018)
- Leon BM, "Diabetes and cardiovascular disease : epidemiology, biological mechanisms, treatment recommendations and future research", World J Diabetes, 6, pp.1246~1258 (2015)
- Yen FS, "Diabetes, hypertension, and cardiovascular disease development", J Transl Med, 20, pp.9~ (2022)
- Tseng LN, "Prevalence of hypertension and dyslipidemia and their associations with micro-and macrovascular diseases in patients with diabetes in Taiwan : an analysis of nationwide data for 2000-2009", J Formos Med Assoc, 111, pp.625~636 (2012)
- Pol T, "Dyslipidemia and risk of cardiovascular events in patients with atrial fibrillation treated with oral anticoagulation therapy : insights from the ARISTOTLE(apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation)trial", J Am Heart Assoc, 7, pp.e007444~ (2018)
- World Health Organization, "Cardiovascular diseases(CVDs)" (2021), World Health Organization
- Hinton W, "Incidence and prevalence of cardiovascular disease in English primary care : a cross-sectional and follow-up study of the Royal College of General Practitioners(RCGP)Research and Surveillance Centre(RSC)", BMJ Open, 8, pp.e020282~ (2018)
- 신현영, "2014년 사망원인 통계", 대한의사협회지, 59(3), pp.221~232 (2016), 대한의사협회[DOI]
- Tao H, "Pre-and post-diagnosis diabetes as a risk factor for all-cause and cancerspecific mortality in breast, prostate, and colorectal cancer survivors:a prospective cohort study", Front Endocrinol (Lausanne), 11, pp.60~ (2020)
- Petrelli F, "Effects of hypertension on cancer survival : a meta-analysis", Eur J Clin Invest, 51, pp.e13493~ (2021)
- Barone BB, "Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus : a systematic review and meta-analysis", JAMA, 300, pp.2754~2764 (2008)
- Ranc K, "Mortality after cancer among patients with diabetes mellitus : effect of diabetes duration and treatment", Diabetologia, 57, pp.927~934 (2014)
- Lee YR, "Statin adherence and risk of allcause, cancer, and cardiovascular mortality among dyslipidemia patients : a time-dependent analysis", Nutr Metab Cardiovasc Dis, 30, pp.2207~2214 (2020)
- Kumar D, "Association of hyperlipidemia with lymph node metastasis in early gastric carcinoma", Int Surg J, 2, pp.187~190 (2015)
- Harding JL, "Trends in cancer mortality among people with vs without diabetes in the USA, 1988-2015", Diabetologia, 63, pp.75~84 (2020)
- Rapsomaniki E, "Blood pressure and incidence of twelve cardiovascular diseases : lifetime risks, healthy life-years lost, and agespecific associations in 1·25 million people", Lancet, 383, pp.1899~1911 (2014)
- Batra A, "Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer", BMC Cancer, 20, pp.1004~ (2020)
- Abdel-Rahman O, "Impact of baseline cardiovascular comorbidity on outcomes in women with breast cancer : a real-world, population-based study", Clin Breast Cancer, 19, pp.e297~e305 (2019)
- Al-Kindi SG, "Prevalence of preexisting cardiovascular disease in patients with different types of cancer : the unmet need for onco-cardiology", Mayo Clin Proc, 91, pp.81~83 (2016)
- Tabuchi T, "Social determinants of health in non-communicable diseases", pp.31~40 (2020), Springer Nature
- 최재우, "Factors associated with the choice of tertiary hospitals in patients with diabetes or hypertension", 병원경영학회지, 21(4), pp.13~22 (2016), 한국병원경영학회
- 조상현, "Cancer Patients’ Utilization of Tertiary Hospitals in Seoul Before and After the Benefit Expansion Policy", 예방의학회지, 52(1), pp.41~50 (2019), 대한예방의학회[DOI]